From research to industry
The French Alternative Energies and Atomic Energy Commission (CEA) is a key player in research, development and innovation.
Discover the main research areas on which the CEA works.
Find the latest scientific and institutional news of the CEA.
The CEA publishes various scientific and technical periodicals and videos. Through them, you can discover the CEA’s major research topics and the latest technological innovations produced by its laboratories.
The CEA Research News is a newsletter bringing to your knowledge the most impacting scientific and societal advances and impacts enabled by major European research projects carried by CEA and which are covering the main priorities of the European Union.
Discover the main research areas on which the CEA is working.
The CEA publishes various scientific and technical periodicals. Through them, you can discover the CEA’s major research topics and the latest technological innovations produced by its laboratories.
The Companies area is intended for firms interested in R&D collaboration with the CEA as well as those seeking to offer their services to the CEA.
CEA is active internationally in a variety of areas: scientific and technical cooperation, sovereign missions, support for French nuclear industry and European community.
The CEA has positioned itself as a key player in building the European research area through its involvement and recognition in numerous European research initiatives and bodies.
The CEA provides the public authorities and the industry with the expertise and innovation needed to develop improved nuclear power generation systems.
The French Alternative Energies and Atomic Energy Commission (CEA) is a key player in research, development and innovation in four main areas: defence and security, nuclear and renewable energies, technological research for industry, fundamental research in the physical sciences and life sciences.
The H2020 Biocapan project, coordinated by the CEA, is developing an innovative cell therapy to supplement a poorly functioning pancreas in patients with type 1 diabetes. The two major goals of this therapy - which involves the use of a revolutionary biocapsule - are to prevent transplanted cells from being rejected and to enable them to perform their function. This will enhance patients’ lives, in particular by eliminating the need for immunosuppressive treatments, which often have severe side-effects.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.